Skip to main content
. Author manuscript; available in PMC: 2011 Oct 1.
Published in final edited form as: J Neuropsychiatry Clin Neurosci. 2011 Fall;23(1):90–97. doi: 10.1176/appi.neuropsych.23.1.90

TABLE 1.

Synaptic Autoimmune Encephalitides

Target Antigen Primary Symptoms Other Manifestations Associated Tumor(s) Demographic Data Outcomes With Proper Therapy
NMDA receptor Psychosis, seizures, autonomic instability, dyskinesias Viral prodrome, changes in speech, catatonic features, hypoventilation Ovarian teratoma* 75% women; 35% children and adolescents 75%–80% substantial improvement or full recovery
AMPA receptor Memory loss, confusion, agitation, seizures Psychotic symptoms, affective changes Breast or lung cancer, thymoma Predominates in women, ages 50–70 Most improve; frequent relapse
GABAB receptor Seizures, memory loss, confusion Hallucinations, paranoia, odd behaviors Small-cell lung cancer Either gender, middle-aged ~50% improve
LGI1 Amnesia, seizures, confusion, disorientation Autonomic dysfunction, apathy/irritability, hyponatremia Rare, thymoma ~2:1 male: female, middle-aged ~80% full recovery or mild deficits
Caspr2 Neuromyotonia, dysautonomia, confusion, insomnia Amnesia, seizures, neuropathic pain, weight loss Rare, thymoma ~4:1 male: female, middle-aged ~80% substantial improvement
*

The association with teratomas is gender- and age-dependent. In women older than 18, ovarian teratomas occur in ~55% of cases. In women younger than 18, teratomas occur in 30% of cases. In women younger than 14, teratomas occur in 9% of cases. Only ~5% of men have an underlying tumor (germ-cell tumor of the testis, neuroblastoma, small-cell lung cancer).11